Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-05

Clinical Trial Update: Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating psilocybin-assisted existential therapy (PEARL) for patients with advanced cancers; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Advanced Cancer, Stage IV Solid Tumor Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING